News, perspectives, and updates from Mentice

In Conversation with Prof. Dr. Jan De Pooter: A Physician’s Perspective on Electrophysiology and Simulation-Based Training.

A Journey Shaped by Curiosity and Collaboration

Advancing Aneurysm Care: Quantifying WEB Device Shape Changes Post-Treatment

Insights from Dr. Ignacio Larrabide 

Mentice has received a $630,000 USD order for simulation solutions from a top 20 global MedTech company

Mentice announced today that it has secured a significant order from a top 20 global Med Tech company, a long-standing customer.

Mentice and The German Society of Interventional Cardiology Announce Strategic Partnership to Refine Cardiovascular Training, Advance Interventional Cardiology, and Improve Patient Outcomes Across Germany

A three-year collaboration to standardize interventional cardiology education through simulation technology and innovative training frameworks.

Mentice receives an order of USD 795,000 for development services from a world-leading MedTech company

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare

Mentice presents financial targets and updated strategic direction to take advantage of current market opportunities

At today’s Capital Markets Day in Stockholm, Mentice executive management team will provide an update on the company’s growth strategy and give an ove

Invitation to Mentice’s Capital Markets Day on 21 March 2024

Mentice AB welcomes investors, analysts and the media to our Capital Markets Day on 21 March 2024 in Stockholm, Sweden.

Mentice and UNICEN Announce Collaboration to Advance Cardiovascular Healthcare Technologies

Mentice, a leading healthcare technology company based in Gothenburg, Sweden, and UNICEN, a prestigious technical university located in Tandil, Argent

Mentice publishes the company’s year-end report for the period January–December 2023

FOURTH QUARTER ENDS A YEAR WITH STRONG GROWTH AND IMPROVED PROFITABILITY

Mentice to present Year-end Report Q4

Mentice AB (STO: MNTC) announces that the company will present its year-end report via webcast conference call with the opportunity for interested par

Mentice receives FDA 510(k) Clearance for ANKYRAS™

Mentice, a healthcare technology company, today announced that the clinical decision support application ANKYRAS™ has received 510(k) clearance

Mentice receives an order of EUR 1,733,200 for simulation solutions from a world leading MedTech company

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare

Mentice enters agreement to acquire all substantial assets from Biomodex, a leading provider of 3D-printed vessels and flow systems

Mentice AB (STO: MNTC), a world leader in simulation solutions for image guided interventional therapies, announced today that it has entered into an

Mentice appoints Ulrika Drotz Voksepp as new Chief Financial Officer

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, appoints Ulrika Drotz Voksepp as CFO, ef

Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2024

At the Annual General Meeting held on 11 May 2023, it was resolved to adopt instructions and rules of procedure for the Nomination Committee, accordin